Vimarsana
Biggest News Aggregation in the World

William Bliar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from William Bliar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In William Bliar Today - Breaking & Trending Today

Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule - CRISPR Therapeutics (NASDAQ:CRSP), Vertex Pharmaceuticals (NASDAQ:VRTX) - Vimarsana News

Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule - CRISPR Therapeutics (NASDAQ:CRSP), Vertex Pharmaceuticals (NASDAQ:VRTX)

FDA approves CRISPR Therapeutics/Vertex's Casgevy a gene-edited cell therapy for transfusion-dependent beta-thalassemia. Vertex's swift launch strategy targets a network of treatment centers across the U.S.

This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis - Enovis (NYSE:ENOV) - Vimarsana News

This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis - Enovis (NYSE:ENOV)

William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth, especially in sub-categories such as extremities, which are growing rapidly due to

This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis - Vimarsana News

This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis

William Bliar has initiated coverage on Enovis Corp ENOV, a medical technology company focusing on the orthopedics market valued at approximately $25 billion,…

Source: biztoc.com
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug - Vimarsana News

Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug

Monday, Lantheus Holdings Inc LNTH and POINT Biopharma Global Inc PNT reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic…

Source: biztoc.com
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug - Lantheus Holdings (NASDAQ:LNTH) - Vimarsana News

Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug - Lantheus Holdings (NASDAQ:LNTH)

Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c